Clinical trial
Ritalin: Antiasthenic Effect of Methylphenidate (Ritalin) in Palliative Care in…
NCT00273741 · University Hospital, Grenoble, Other · Terminated
Key facts
| NCT number | NCT00273741 |
|---|---|
| Title | Ritalin: Antiasthenic Effect of Methylphenidate (Ritalin) in Palliative Care in Cancer Patients |
| Official title | Randomized Study Evaluating the Antiasthenic Effect of Methylphenidate (Ritalin) in Palliative Care in Cancer Patients |
| Acronym | Ritaline |
| Lead sponsor | University Hospital, Grenoble, Other |
| Collaborators | Fondation de France Ligue contre le cancer, France |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthenia, Neoplasms |
| Intervention type | Drug |
| Interventions | methylphenidate, placebo comparator |
| Enrollment | 39 |
| Start date | Jan 1, 2007 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Jan 9, 2006 |
| Last update posted | Dec 7, 2009 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: